Provided by Tiger Trade Technology Pte. Ltd.

OCUMENSION-B

5.190
-0.095-1.80%
Volume:742.00K
Turnover:3.79M
Market Cap:4.23B
PE:-22.26
High:5.340
Open:5.340
Low:5.000
Close:5.285
52wk High:12.070
52wk Low:4.040
Shares:815.00M
HK Float Shares:815.00M
Volume Ratio:3.16
T/O Rate:0.09%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.233
ROE:-4.26%
ROA:-2.48%
PB:0.99
PE(LYR):-22.26
PS:4.51

Loading ...

LAEKNA-B Shares Surge Over 10% in Afternoon Trading as Qilu Pharmaceutical Advances LAE002 NDA; Company Poised for Upfront and Milestone Payments

Stock News
·
May 11

Angelini Pharma Acquires Catalyst Pharmaceuticals in $4.1 Billion Deal

Deep News
·
May 07

Hainan Poly Pharm Investor Claims Submitted for Court Filing Following Prior Successful Verdict

Deep News
·
May 07

LAEKNA-B Shares Surge Over 5% in Late Trading as Qilu Pharma Advances Domestic Application for LAE002

Stock News
·
May 07

Pharmaceutical Supply Chain Shows Clear Signs of Upturn, Driven by Domestic and International Demand

Stock News
·
May 07

Ocumension Maintains Share Structure in April; Option Lapses Trim Outstanding Grants

Bulletin Express
·
May 06

Pharmaceutical Sector Shows Divergence with Innovative Drugs Segment Experiencing Rapid Growth

Stock News
·
May 06

ASCLETIS-B (01672) to Present Multiple Program Data at 33rd European Congress on Obesity (ECO 2026)

Stock News
·
May 06

Bubble Alert: Weight-Loss Drug Boom Drives Industry Surge, Pharma Sector Faces Hidden Risks

Deep News
·
May 04

Deloitte Analysis: Growth Driven by Weight-Loss Drugs Puts Pharmaceutical Sector at Risk

Deep News
·
May 04

In-Depth Analysis of Guotai Haitong's Regulatory Warning: Gatekeeper Failures in Puli Pharmaceutical Fraud Case

Deep News
·
May 03

ASCLETIS-B Shares Climb Over 3% in Morning Session on Upcoming ADA 2026 Conference Presentations

Stock News
·
Apr 30

ASCLETIS-B to Present Multiple Project Findings at ADA 2026 Scientific Sessions

Stock News
·
Apr 30

Eli Lilly Emerges as Top Contender in Pharma's AI Arms Race with $2.25 Billion Profluent Partnership for DNA Editing Tech

Stock News
·
Apr 28

Ocumension Issues Reminder to Shareholders on Mandatory Shift to Electronic Corporate Communications

Bulletin Express
·
Apr 28

Ocumension Therapeutics publishes 2025 annual report

Reuters
·
Apr 28

OCUMENSION-B 2025年营收大增92.7%,核心产品与国际合作助力业绩显著改善

Bulletin Express
·
Apr 28

Ligan Pharmaceuticals to Acquire Zoma Corporation for Nearly $740 Million

Deep News
·
Apr 27

Pharmaceutical Sector Welcomes New Powerhouse: Sun Pharma Acquires Organon in $11.75 Billion Deal

Stock News
·
Apr 27

ASCLETIS-B Completes Patient Enrollment for US Phase II Trial of Oral GLP-1R Agonist ASC30 in Diabetes

Stock News
·
Apr 27